Cancer incidence and mortality in China, 2022
Bingfeng Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(First Affiliated Hospital of Jinan University), Wenqiang Wei(Chinese Academy of Medical Sciences & Peking Union Medical College), Kexin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Rongshou Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongmei Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Ru Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Shaoming Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 1,977
Related Papers
Cancer incidence and mortality in China, 2016
|Journal of the National Cancer Center|2022|1.6k
Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020
|Cancer Communications|2021|1.1k
Cancer registration in China and its role in cancer prevention and control
|The Lancet Oncology|2020|501
Cancer deaths and cases attributable to lifestyle factors and infections in China, 2013
|Annals of Oncology|2017|444
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415